Perfint Healthcare aims for USD 100 mn turnover by 2016

NEW DELHI, June 3: Medical equipment maker Perfint Healthcare has set an ambitious target of achieving USD 100 million (over Rs 550 crore) turnover in the next four years on the back of expansion in emerging markets.
The Chennai-headquartered firm, which manufactures medical equipment primarily to treat cancer through robotic intervention, reported a turnover of USD 4.7 million in FY12. It is targeting around USD 12 million in the current fiscal.
“We are looking at USD 100 million turnover by 2016 with the majority of the revenues coming from emerging countries,” Perfint Healthcare CEO Nanda Kumar S told.
At present, the company sells two products under the brand Robio and Piga in South East Asian countries, US and Europe apart from India. These are manufactured at Chennai.
“We are looking at various emerging markets including China, Korea, Japan, India and Eastern European nations for sales. We estimate that 20 per cent of the revenue would come from North America and Europe, while the rest from emerging markets,” Kumar said.
He said the company is adding new products to enhance its portfolio as part of the strategy to grow sales by over 20-fold by 2016.
It has developed a cancer treatment equipment—Maxio, which it plans to sell in global markets by September this year.
“Shipments of Maxio would start in September, as soon as we get regulatory approvals in the US, Europe, Japan, Korea, Brazil and Canada,” Kumar said.
While Robio and Piga are used to deliver medicines for pain elimination, Maxio, with the help of robotic intervention treats cancer through tumour ablation, a process in which tumour is burnt or freezed by inserting a needle in the affected area.
The company is also looking to raise Rs 100 crore in September to fund new product development, expansion as well as regulatory approvals, Kumar said.
The company, which has regional offices in various countries including Thailand and Turkey, has applied for regulatory approvals in various countries to sell its new product. (PTI)